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Abstract
Background: Prenatal exposure of mother to valproate (VPA) causes teratogenic effects in the fetus, namely fetal
valproate syndrome (FVS). We report a case of fetal valproate syndrome rarely diagnosed by prenatal sonographic
examination.
Case presentation: Our patient was a female infant who was born to a 27-year-old nulliparous Japanese woman with
epilepsy. The mother was diagnosed with infantile epilepsy at 1 year of age and had been using three antiepileptic drugs,
including valproate, but preconceptional counseling was not performed. At 25 weeks of gestation, contracture of the fetal
right wrist joint suggestive of a radial ray defect was observed by transabdominal ultrasonography. The fetus demonstrated
growth retardation starting from 32 weeks of gestation. In addition, saddle nose as a facial anomaly was detected by
three-dimensional ultrasound at 37 weeks of gestation. Accordingly, we suspected that the fetus had fetal valproate
syndrome. At 39 weeks of gestation, the mother delivered an infant weighing 2056 g. The neonate had characteristic
features of fetal valproate syndrome, such as facial configuration, slight muscular hypotonia of the whole body,
breathing problems, right-hand articular contracture accompanied by radial ray defect, and cardiovascular malformation.
Conclusions: When obstetricians manage epileptic pregnant women without enough preconceptional counseling or
adjustment for antiepileptic drugs, careful sonographic observation of the fetus is mandatory.
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Background
Valproate (VPA) is used for the treatment of epilepsy
and mood disorders [1]. Prenatal exposure of the mother
to VPA causes teratogenic effects in the fetus, namely
fetal valproate syndrome (FVS). FVS is characterized by
a number of abnormalities, including neural tube
defects; congenital heart defects; limb defects; genitouri-
nary defects; brain, eye, and respiratory anomalies; and
abdominal wall defects [2]. Although FVS is well-known
as a newborn disease, reports of prenatal ultrasono-
graphic diagnosis are limited, and only two cases have
been reported in the English-language literature. We
report another case of FVS diagnosed by prenatal ultra-
sonography. Careful ultrasonographic observation might
be useful for predicting FVS in pregnant women using
antiepileptic drugs, including high-dose VPA, without
enough preconceptional counseling.
Case presentation
Our patient was a female infant who was born to a
27-year-old Japanese nulliparous woman. The mother
had been diagnosed with infantile epilepsy at 1 year
of age. Her antiepileptic therapy was discontinued at
the age of 7 years because she had no symptoms, but
she had an epileptic seizure at the age of 17 years,
and treatment with the antiepileptic drugs was
resumed. She married at the age of 25 years; however,
she did not receive preconceptional consultation.
Because she had slight mental retardation, she did
not report her wish for a pregnancy to her physician.
At the age of 27 years, she was referred to our
hospital from a primary obstetrical clinic at 13 weeks
of gestation. She was obese, with a body mass index
of 30 kg/m2. The antiepileptic drugs she was taking
included 1400 mg/day of VPA, 140 mg/day of pheno-
barbital (PB), and 1200 mg/day of carbamazepine
(CBZ). The blood concentrations of the drugs were
80 μg/ml VPA (effective blood range is from 40 to
100 μg/ml), 26.1 μg/ml PB (10–30 μg/ml), and 10.5 μg/ml
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CBZ (4–12 μg/ml). Despite the mother’s use of three anti-
epileptic drugs, she had convulsions about three times per
week. Therefore, reduction or alteration of the drugs was
difficult. She was informed of her epileptic status and the
teratogenic effects of VPA, but her wish to have a baby
was so strong that she continued her pregnancy with oral
folic acid of 5 mg/day.
Although second-trimester transabdominal ultrason-
ography was performed at 20 weeks of gestation, fetal
malformation was not detected because of a poor ultra-
sound image due to maternal obesity. At 25 weeks of
gestation, contracture of the fetal right wrist joint sug-
gestive of a radial ray defect was detected by ultrason-
ography (Fig. 1a, b). The fetus demonstrated growth
retardation starting from 32 weeks of gestation. After that,
fetal ultrasonography was performed weekly until delivery.
At 34 weeks of gestation, the estimated fetal weight was
1660 g (−2.5 SD: standard deviation), the biparietal diam-
eter was 74.9 mm (−2.8 SD), mother’s abdominal circum-
ference was 261.7 mm (−1.5 SD), and the femur length
was 58 mm (−1.3 SD). The right ulna was shorter than the
left ulna; the right was 35 mm (−8.4 SD), and the left was
53 mm (−1.1 SD). The right radial ray was not detected.
At 37 weeks of gestation, saddle nose as a facial anomaly
was observed on a three-dimensional ultrasound (Fig. 1c).
Therefore, right radial ray defect and saddle nose caused
by FVS were suspected.
The serum levels of antiepileptic drugs were within
effective ranges; however, multiple syncopes occurred.
Fetal growth retardation was not improved, but growth
arrest was not observed. The mother went into active
labor at 39 weeks and 2 days of gestation and delivered a
female infant weighing 2056 g with Apgar scores of 8
and 8 at 1 and 5 minutes, respectively. The neonate
showed slight muscular hypotonia of the whole body
and respiratory distress. The neonate’s physical examin-
ation revealed bend and contracture of the right wrist
joint (Fig. 2a), right radial ray defect (Fig. 2b), a ventricu-
lar septal defect (VSD), an atrial septal defect (ASD),
and a patent ductus arteriosus (PDA) in addition to
characteristic facial configurations such as euryopia,
broad nasal root, saddle nose, shallow philtrum, and
low-set ears. The neonate’s features were compatible
with FVS. PDA ligation was performed when she was 13
days old, and cast immobilization of the right forward
arm was started when she was 89 days old. A follow-up
examination at age 12 months demonstrated develop-
mental and growth retardation.
Discussion
The recommended treatment for a woman with epilepsy
who wishes to have children is to use a single drug or
newer antiepileptic drugs such as lamotrigine or leveti-
racetam [3–5]. Although avoidance of VPA is an option
Fig. 1 Prenatal ultrasonographic image. a Contracture of the fetal right wrist joint is observed at 25 weeks of gestation. b Schematic image of the
right wrist joint. c Saddle nose as a facial anomaly is observed on this three-dimensional ultrasound obtained at 37 weeks of gestation
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to prevent FVS, there are cases where the control of
convulsions is impossible without VPA. There is a dose-
effect relationship between fetal malformations and VPA
exposure during the first trimester of pregnancy; that is,
higher VPA doses are associated with a significantly
greater risk than lower doses. Several investigators have
reported a higher fetal malformation risk with maternal
VPA doses above 1000 mg/day or high blood concentra-
tions above 70 μg/ml during pregnancy [6]. Combined
use of antiepileptic drugs is also associated with a high
risk of fetal malformations. The risk of major congenital
malformations is influenced not only by the type of anti-
epileptic drug used but also by dose and other variables,
which should be taken into account in the management
of epilepsy in women of childbearing potential [4]. Thus,
preconceptional counseling for a woman with epilepsy
who is taking antiepileptic drugs is very important.
When a woman who is being treated with antiepileptic
drugs, including VPA conceives, careful ultrasonographic
observation of the fetus might be useful for predicting
FVS. Witters et al. reported that prenatal nuchal edema
could be the first presenting sign of FVS [7]. Because
infants with FVS sometimes have multiple congenital
heart diseases, this finding is reasonable and useful for
predicting FVS. Contrary to our prediction, most reports
of FVS have occurred in neonates and children, and we
found only two reports that provided prenatal sono-
graphic representations of FVS [7, 8] (Table 1). Witters
et al. [7] reported an ultrasonographic feature of a fetal
flat nasal bridge with a short nose at 21 weeks of gesta-
tion. The following pregnancy course was uneventful in
their case, and the baby was born at term. The infant
also had dysmorphic features seen in FVS: a long phil-
trum, thin upper lip, and long toes with a short fifth toe
[7]. Kennelly and Moran [8] described a radial ray defect
visualized by two- and three-dimensional prenatal ultra-
sonography at 19 weeks of gestation. The pregnancy was
terminated, and the baby was revealed to have aortic
valve stenosis postnatally [8]. In our case, contracture of
the fetal wrist joint suggestive of a radial ray defect and
saddle nose as a facial anomaly were detected by
prenatal ultrasonography, indicating that the detection
of these findings is a hallmark for precise prenatal diag-
nosis of FVS. In addition, the present case is the first
a b
Fig. 2 a The neonate’s physical examination reveal bend and contracture of right wrist joint. b A right radial ray defect is observed on this x-ray (arrow)





US findings of fetus
(gestational weeks)
Delivery Additional postnatal findings
Witters et al. 2002 [7] 40 years VPA; 1000 mg/day Flat nasal bridge with
short nose (21 weeks)
Term-delivery female Long philtrum, thin upper lip, long toes
Kennelly and Moran
2007 [8]
N/A VPA; dose N/A Bilateral radial ray
defects (19 weeks)
Termination of pregnancy Aortic valve stenosis





of radial ray defect
(25 weeks)
Term-delivery female VSD, ASD, PDA; shallow philtrum; euryopia
Saddle nose (37 weeks)
Abbreviations: US Ultrasonography, VPA Valproate, PB Phenobarbital, CBZ Carbamazepine, VSD Ventricular septal defect, ASD Atrial septal defect, PDA Patent ductus
arteriosus, N/A Not available
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case of FVS in which both contracture of the wrist joint
and saddle nose were observed prenatally. In our case,
fetal cardiac malformation, including ASD and VSD, was
not detected prenatally because of a poor ultrasound
image due to maternal obesity.
When radial ray defects and facial anomaly are observed
by prenatal ultrasonography, differential diagnoses of FVS
are trisomy 18, trisomy 13, Cornelia de Lange syn-
drome, Roberts syndrome, acrofacial dysostosis, Baller-
Gerold syndrome, Fanconi anemia, Aase syndrome,
thrombocytopenia-absent radius (TAR) syndrome, and
Holt-Oram syndrome [8]. The facial anomaly in FVS is
usually flat nasal bridge or saddle nose; facial anomalies
seen in other syndromic disorders are micrognathia (tri-
somy 18, Cornelia de Lange syndrome, acrofacial dysosto-
sis, Baller-Gerold syndrome, and TAR (thrombocytopenia
with absent radius) syndrome, cleft lip and/or palate (tri-
somy 13, Roberts syndrome, and Aase syndrome), man-
dibular protrusion (Cornelia de Lange syndrome),
microphthalmus (Fanconi anemia), and hypertelorism
(Holt-Oram syndrome) [8]. VACTERL association (verte-
bral anomalies, anal atresia, cardiovascular anomalies, tra-
cheoesophageal fistula, esophageal atresia, renal (kidney)
and/or radial anomalies, limb defects) is associated with
radial ray defects, but it is not usually accompanied by facial
anomaly [8]. Although Binder syndrome is characterized by
a flat midface and nasal hypoplasia, it is not usually accom-
panied by radial ray defects [9].
Conclusions
The present case indicated the possibility of prenatal
diagnosis of FVS using ultrasonography. Especially,
detection of contracture of the fetal wrist joint and
saddle nose seemed to have diagnostic value. When ob-
stetricians manage women with epilepsy using epileptic
drugs without preconceptional counseling, meticulous
ultrasonographic observation should be performed to
prevent serious morbidity and mortality in postnatal
life. Furthermore, when multiple malformations to an
extensive degree exist, early prenatal diagnosis may lead
to more appropriate management of FVS, including
termination of pregnancy and providing counseling for
future pregnancies.
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